[go: up one dir, main page]

NO861366L - N-indolyletylsulfonsyreamider og fremgangsmaater til fremstilling derav. - Google Patents

N-indolyletylsulfonsyreamider og fremgangsmaater til fremstilling derav.

Info

Publication number
NO861366L
NO861366L NO861366A NO861366A NO861366L NO 861366 L NO861366 L NO 861366L NO 861366 A NO861366 A NO 861366A NO 861366 A NO861366 A NO 861366A NO 861366 L NO861366 L NO 861366L
Authority
NO
Norway
Prior art keywords
indolylethyl
acid amides
sulphonic acid
procedures
preparing
Prior art date
Application number
NO861366A
Other languages
English (en)
Other versions
NO167283C (no
NO167283B (no
Inventor
Horst Boeshagen
Ulrich Rosentreter
Folker Lieb
Hermann Oediger
Friedel Seuter
Elisabeth Perzborn
Volker-Bernd Fiedler
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO861366L publication Critical patent/NO861366L/no
Publication of NO167283B publication Critical patent/NO167283B/no
Publication of NO167283C publication Critical patent/NO167283C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16—Tryptamines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Peptides Or Proteins (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO861366A 1985-04-24 1986-04-08 Analogifremgangsmaate for fremstilling av terapeutisk aktive n-indolyletylsulfonsyreamider. NO167283C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19853514696 DE3514696A1 (de) 1985-04-24 1985-04-24 N-indolylethyl-sulfonsaeureamide, verfahren zu ihrer herstellung und ihre verwendung

Publications (3)

Publication Number Publication Date
NO861366L true NO861366L (no) 1986-10-27
NO167283B NO167283B (no) 1991-07-15
NO167283C NO167283C (no) 1991-10-23

Family

ID=6268925

Family Applications (1)

Application Number Title Priority Date Filing Date
NO861366A NO167283C (no) 1985-04-24 1986-04-08 Analogifremgangsmaate for fremstilling av terapeutisk aktive n-indolyletylsulfonsyreamider.

Country Status (18)

Country Link
US (1) US4774240A (no)
EP (1) EP0201735B1 (no)
JP (1) JPH0625104B2 (no)
KR (1) KR930011299B1 (no)
CN (1) CN1015054B (no)
AT (1) ATE56433T1 (no)
AU (1) AU590267B2 (no)
CA (1) CA1321585C (no)
DE (2) DE3514696A1 (no)
DK (1) DK187186A (no)
ES (1) ES8802381A1 (no)
FI (1) FI82036C (no)
GR (1) GR861058B (no)
HU (1) HU195483B (no)
IL (1) IL78557A0 (no)
NO (1) NO167283C (no)
PT (1) PT82442B (no)
ZA (1) ZA863028B (no)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3613623A1 (de) * 1986-04-23 1987-10-29 Bayer Ag N-dihydroindolylethyl-sulfonamide
GB8717374D0 (en) * 1987-07-22 1987-08-26 Smith Kline French Lab Pharmaceutically active compounds
DE3840338A1 (de) * 1988-11-30 1990-05-31 Bayer Ag Neue 2-halogensubstituierte n-indolylethyl-sulfonsaeureamide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
US5153214A (en) * 1989-06-28 1992-10-06 Ciba-Geigy Corporation Certain (arylsulfonamido- and imidazolyl-)-substituted carboxylic acids and derivatives thereof and use for suppressing thromboxane activity
US5025025A (en) * 1989-06-28 1991-06-18 Ciba-Geigy Corporation (Arylsulfonamido- and pyridyl-)-substituted carboxylic acids and derivatives thereof and use for suppressing thromboxane activity
GB8924392D0 (en) * 1989-10-30 1989-12-20 Bayer Ag Substituted cycloalkano/b/dihydroindole-and-indolesulphonamides
GB9008108D0 (en) * 1990-04-10 1990-06-06 Bayer Ag Cycloalkano(b)dihydroindoles and-indolesulphonamides substituted by heterocycles
WO1991018897A1 (en) * 1990-06-07 1991-12-12 The Wellcome Foundation Limited Therapeutic heterocyclic compounds
US5189054A (en) * 1990-11-02 1993-02-23 Merrell Dow Pharmaceuticals Inc. 3-amidoindolyl derivatives and pharmaceutical compositions thereof
US7605156B2 (en) * 2001-12-03 2009-10-20 Wyeth Methods for the use of inhibitors of cytosolic phospholipase A2
DE60318188T2 (de) * 2002-03-26 2008-12-11 Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield Glucocorticoid-mimetika, deren herstellung, pharmazeutische zusammensetzungen und verwendung
US7534897B2 (en) * 2002-05-16 2009-05-19 Shionogi & Co., Ltd. Indole arylsulfonaimide compounds exhibiting PGD 2 receptor antagonism
EP1539141B1 (en) * 2002-08-29 2010-07-14 Boehringer Ingelheim Pharmaceuticals Inc. 3-(sulfonamidoethyl)-indole derivatives for use as glucocorticoid mimetics in the treatment of inflammatory, allergic and proliferative diseases
UY28526A1 (es) * 2003-09-24 2005-04-29 Boehringer Ingelheim Pharma Miméticos de glucocorticoides, métodos de preparación composiciones farmacéuticas y usos de los mismos
US7795272B2 (en) * 2004-03-13 2010-09-14 Boehringer Ingelheim Pharmaceutical, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
US7754755B2 (en) * 2004-09-23 2010-07-13 Bristol-Myers Squibb Company Inhibitors of 15-lipoxygenase
BRPI0517263A (pt) * 2004-10-29 2008-10-07 Astrazeneca Ab novos derivados de sulfonamida como moduladores do receptor de glicocorticóide para o tratamento de doenças inflamatórias
JP2008525525A (ja) * 2004-12-27 2008-07-17 ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド グルココルチコイドミメティクス、その製法、医薬組成物及び使用
TW200829578A (en) 2006-11-23 2008-07-16 Astrazeneca Ab Chemical compounds 537
CA2671990A1 (en) * 2006-12-06 2008-06-12 Boehringer Ingelheim International Gmbh Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
JO2754B1 (en) 2006-12-21 2014-03-15 استرازينكا ايه بي Amylendazoleil derivatives for the treatment of glucocorticoid-mediated disorders
US7750027B2 (en) * 2008-01-18 2010-07-06 Oxagen Limited Compounds having CRTH2 antagonist activity
UY31832A (es) 2008-05-20 2010-01-05 Astrazeneca Ab Derivados de indazol sustituidos con fenilo y benzodioxinilo
AU2009256289A1 (en) * 2008-06-06 2009-12-10 Boehringer Ingelheim International Gmbh Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
GB201407820D0 (en) 2014-05-02 2014-06-18 Atopix Therapeutics Ltd Polymorphic form
GB201407807D0 (en) 2014-05-02 2014-06-18 Atopix Therapeutics Ltd Polymorphic form
CN105399697A (zh) * 2014-09-12 2016-03-16 苏州旺山旺水生物医药有限公司 一种氨基磺酰基类化合物、其制备方法及用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1332410C (en) * 1984-06-26 1994-10-11 Roger M. Freidinger Benzodiazepine analogs

Also Published As

Publication number Publication date
HUT41385A (en) 1987-04-28
FI861683A (fi) 1986-10-25
DE3514696A1 (de) 1986-11-06
KR930011299B1 (ko) 1993-11-29
GR861058B (en) 1986-08-19
CA1321585C (en) 1993-08-24
ATE56433T1 (de) 1990-09-15
FI82036B (fi) 1990-09-28
KR860008137A (ko) 1986-11-12
JPH0625104B2 (ja) 1994-04-06
ES8802381A1 (es) 1988-05-16
HU195483B (en) 1988-05-30
NO167283C (no) 1991-10-23
ZA863028B (en) 1987-12-30
FI861683A0 (fi) 1986-04-22
CN1015054B (zh) 1991-12-11
DE3674059D1 (de) 1990-10-18
JPS61249960A (ja) 1986-11-07
DK187186A (da) 1986-10-25
NO167283B (no) 1991-07-15
CN86102761A (zh) 1987-02-25
EP0201735A1 (de) 1986-11-20
US4774240A (en) 1988-09-27
AU590267B2 (en) 1989-11-02
DK187186D0 (da) 1986-04-23
PT82442A (en) 1986-05-01
EP0201735B1 (de) 1990-09-12
FI82036C (fi) 1991-01-10
ES554285A0 (es) 1988-05-16
IL78557A0 (en) 1986-08-31
AU5672686A (en) 1986-10-30
PT82442B (pt) 1988-11-30

Similar Documents

Publication Publication Date Title
NO861366L (no) N-indolyletylsulfonsyreamider og fremgangsmaater til fremstilling derav.
NO903851D0 (no) Fremgangsmaate for fremstilling av n-substituerte-4-pyrimidinaminer og -pyrimidindiaminer, og deres anvendelse som medikamenter.
IS3156A7 (is) Aðferð við framleiðslu á N1-súbstitúeruðum bensimidasólafleiðum til að nota við lækningar
NO931482D0 (no) Farmasoeytiske sammensetninger inneholdende quinolin- og quinazolinderivater og nye forbindelser for disse
DK163287D0 (da) 1,4-diazepiner og farmaceutiske midler med indhold af saadanne forbindelser
SE8301008L (sv) Pyrrolacetamider med antiinflammatorisk verkan
SE8801845L (sv) Farmakologiskt aktiva substituerade bensa mider
DK204686A (da) Quinolylglycinamidderivater og fremgangsmaade til fremstilling deraf
SE8802412D0 (sv) Thiourea derivatives
DK469687D0 (da) Derivater af 4,5-dihydrooxazoler og fremgangsmaade til fremstilling af saadanne derivater.
DE3778642D1 (de) Therapeutikum zur behandlung von magengeschwueren.
IE860987L (en) Triazole derivatives
NO840732L (no) Analogifremgangsmaate for fremstilling av den terapeutisk aktive forbindelse n-(3-trifluormetylfenyl)-n`-propargylpiperazin
IL61769A (en) 2-(n-(halosubstitutedphenyl)-n-(thienyl-2-methyl)-amino)-2-imidazolines,their preparation and pharmaceutical compositions containing them
NO151465C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolderivater og syreaddisjonssalter derav
NO168642C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktivt 2-(formylamino)-n-(1h-tetrazol-5-yl)benzamid.
NO883987D0 (no) Fremgangsmaate for fremstilling av n-(substituert aklyliden) kondensert bicykloalkyliden og anvendelse derav som medikamenter.
DK222886A (da) Propionylanilider, fremgangsmaade til fremstilling heraf og farmaceutiske praeparater indeholdende disse forbindelser